Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06023706
PHASE3

Study Evaluating the Analgesic Efficacy of Capsaicin 8% Patches in Chronic Coccygodynia.

Sponsor: Nantes University Hospital

View on ClinicalTrials.gov

Summary

The primary objective is to demonstrate the analgesic effect at day 60 of 8% capsaicin patch (Qutenza) for the treatment of patients with coccygodyinia.

Official title: Phase 3 Confirmatory, Randomised 1:1 Double-blind, Placebo-controlled Study Evaluating the Analgesic Efficacy of Capsaicin 8% Patches in Chronic Coccygodynia.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

188

Start Date

2023-11-08

Completion Date

2027-06-08

Last Updated

2026-02-24

Healthy Volunteers

No

Interventions

DRUG

Capsaicin 179 Mg Cutaneous Patch

1 patch applied once for 1 hour

DRUG

Capsaicin low concentration patch (capsaicin 0,04%, 3,2 mg/cm2)

1 patch applied once for 1 hour

Locations (6)

Brest University Hospital

Brest, France

Vendée Departmental Hospital

La Roche-sur-Yon, France

Confluent Private Hospital Centre

Nantes, France

Nantes University Hospital

Nantes, France

GH Paris saint Joseph

Paris, France

Rouen University Hospital

Rouen, France